Order Article Reprints

Peterson J, Van Twuijver E, Versage E, Hohenboken M. Phase 3 Randomized, Multicenter, Placebo-Controlled Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of an Adjuvanted Cell Culture-Derived, H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects. Vaccines. 2022; 10(4):497. https://doi.org/10.3390/vaccines10040497

Peterson, James, Esther Van Twuijver, Eve Versage, and Matthew Hohenboken. 2022. "Phase 3 Randomized, Multicenter, Placebo-Controlled Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of an Adjuvanted Cell Culture-Derived, H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects" Vaccines 10, no. 4: 497. https://doi.org/10.3390/vaccines10040497

Peterson, J., Van Twuijver, E., Versage, E., & Hohenboken, M. (2022). Phase 3 Randomized, Multicenter, Placebo-Controlled Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of an Adjuvanted Cell Culture-Derived, H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects. Vaccines, 10(4), 497. https://doi.org/10.3390/vaccines10040497